Venizelos Vasileios

Director, Breast Unit & Breast Surgery Clinic

President, Hellenic Society of Breast Surgeons

Member, American Society of Breast Surgeons

• Registrar/Senior Registrar in surgery departments in Manchester, Warwick and Preston
• Registrar, Breast Department, Christie's Cancer Center, Manchester, UK
• Staff Breast Surgeon, Breast Unit, Edinburgh, Scotland
• Consultant Breast Surgeon, Breast Unit, Edinburgh, Scotland
• 2009-currently: Director, Breast Unit, Metropolitan Hospital
• 2005-2009: Director, Breast Clinic, Athens Euroclinic
• 2003-2006: Associate Director, Breast Surgery Clinic, 6th IKA Infirmary
• 2000-2003: Associate Director, Breast Center, LETO Maternity Hospital

Undergraduate Studies

Bachelor’s Degree, Faculty of Medicine, National and Kapodistrian University of Athens

Academic Titles

• MPhil Degree in Breast Cancer, University of Manchester, UK
• Guest speaker at more than 100 conferences with topics relating to breast disorders

Special Clinical Interests and Specialty

• 1995-1999: Specialty in Breast Surgical Oncology, Manchester and Edinburgh Breast Units
• Oncoplastic breast surgery
• Preoperative diagnosis using ultrasound-guided percutaneous biopsy
• Breast reconstruction following mastectomy

• Clinical Associate Professor. Department of Basic and Clinical Sciences. University of Nicosia, Cyprus
• Invited lecturer. Lecture series for the MSc program “Breast Diseases”. Director: Prof N. Arkadopopulos; School of Health Sciences, Medical School, National and Kapodistrian University of Athens. 2023-2024, 2024-2025
• Supervisor of research projects conducted at Metropolitan’s Hospital Surgical Breast Unit

Book Chapters

• Contribution on scientific decision-making: National Guidelines in the Surgical Oncology of the Breast, Paschalidis Medical Publications, 2013 (ISBN 978-618-80270-3-9), 1^st Propaedeutic Surgical Department, Prof. G. Zografos
• Gravvanis A., Kakagia D., Ramakrishnan V. (2022), Clinical Scenarios in Reconstructive Microsurgery, Strategy and Operative Technique, 1^st Edition, 1083 pages, Springer Nature Switzerland (ISBN: 983-3-030-23705-9 and eBook ISBN: 978-3-030-23706-6). Chapter 86: DIEP Flap Reconstruction in a Slim Patient. pages:923-934

Publications in International Peer Reviewed Journals

• Kühn, T., Banys-Paluchowski, M., Ditsch, N., Stickeler, E., Hauptmann, M., Schroth, J., Karadeniz Cakmak, G., Hahn, M., Thill, M., Reimer, T., Fröhlich, S., Schmidt, E., Wihlfahrt, K., Berger, T., Basali, T., Ruf, F., Rief, A., Lux, M. P., Kolberg, H. C., Rubio, I. T., et al, AXSANA Study Group (2025). Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study. The British journal of surgery, 112(9), znaf180. https://doi.org/10.1093/bjs/znaf180
• Iosifidou, R., Kapetsis, G., Giannoulakis, S., Tsoulos, N., Xepapadakis, G., Markopoulos, C., ... & Venizelos, V. (2025). Genomic Risk Evaluation Using Oncotype DX in Young Women (Aged≤ 40) With Early-stage, ER-positive, Human Epidermal Growth Factor Receptor 2-negative, and Node-negative Breast Cancer. Journal of Young Womens Breast Cancer and Health, 2(1), 27-33.
• Hartmann, S., Banys-Paluchowski, M., Berger, T., Ditsch, N., Stickeler, E., de Boniface, J., Gentilini, O. D., Schroth, J., Karadeniz Cakmak, G., Rubio, I. T., Gasparri, M. L., Kontos, M., Bonci, E. A., Niinikoski, L., Murawa, D., Kadayaprath, G., Pinto, D., Peintinger, F., Schlichting, E., Dostalek, L.et al, AXSANA Study Group (2025). Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 51(9), 110253. https://doi.org/10.1016/j.ejso.2025.110253
• Catanuto, G., Gentile, D., Martorana, F., Tomatis, M., Ponti, A., Marotti, L., Aristei, C., Cardoso, M. J., Cheung, K. L., Curigliano, G., De Vries, J., Karakatsanis, A., Santini, D., Sardanelli, F., Van Dam, P., Rubio, I. T., & EUSOMA Working Group (2025). Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 51(6), 109643. https://doi.org/10.1016/j.ejso.2025.109643
• Kontos, M., Kanavidis, P., Kühn, T., Masannat, Y., Gulluoglu, B., & TAD Study Group (2024). Targeted axillary dissection: worldwide variations in clinical practice. Breast cancer research and treatment, 204(2), 389–396. https://doi.org/10.1007/s10549-023-07204-7
• Tvedskov, T. F., Szulkin, R., Alkner, S., Andersson, Y., Bergkvist, L., Frisell, J., Gentilini, O. D., Kontos, M., Kühn, T., Lundstedt, D., Offersen, B. V., Bagge, R. O., Reimer, T., Sund, M., Rydén, L., Christiansen, P., de Boniface, J., & SENOMAC Trialists' Group (2024). Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trial. The Lancet regional health. Europe, 47, 101083. https://doi.org/10.1016/j.lanepe.2024.101083
• Tsoulos N, Papadopoulou E, Agiannitopoulos K, Grigoriadis D, Tsaousis GN, Bouzarelou D, Gogas H, Troupis T, Venizelos V, et al. (2024). Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation. C.Diagnostics (Basel); 14(16):1826
• Tsoulos N, Agiannitopoulos K, Potska K, Katseli A, Ntogka C, Pepe G, Bouzarelou D, Papathanasiou A, Grigoriadis D, Tsaousis GN, Gogas H, Troupis T, Papazisis K, Natsiopoulos I, Venizelos V, et al (2024). The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer Genomics Proteomics; 21(5):448-463
• De Boniface J, Filtenborg Tvedskov T, Rydén L, Szulkin R, Reimer T, Kühn T, Kontos M, Gentilini OD, Olofsson Bagge R, Sund M, Lundstedt D, Appelgren M, Ahlgren J, Norenstedt S, et al. (2024). Omitting Axillary Dissection in Breast Cancer with Sentinel Node Metastasis. N Engl J Med; 390(13):1163-1175
• Kontos M, Kanavidis P, Kühn T, Masannat Y, Gulluoglu B; TAD Study Group. Collaborator: Venizelos V. (2024) Targeted axillary dissection worldwide variations in clinical practice. Breast Cancer Res Treat; 204(2):389-396
• Agiannitopoulos, Konstantinos; Potska, Kevisa; Katseli, Anastasia; Ntogka, Christina; Tsaousis, Georgios N; et al. (2023). Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing. Cancers, 15.0(21), 5218
• Agiannitopoulos, K., Pepe, G., Tsaousis, G. N., Potska, K., Bouzarelou, D., Katseli, A.,et al. (2023). Copy Number Variations (CNVs) account for 10.8% of pathogenic variants in patients referred for hereditary cancer testing. Cancer Genomics & Proteomics, 20(5), 448-45
• Zagouri, Flora; Koliou, Georgia-Angeliki; Dimitrakopoulos, Foteinos; Papadimitriou, Christos; Binas, Ioannis; Koutras, Angelos; Papakostas, Pavlos; Markopoulos, Christos; Venizelos, Vasileios; Xepapadakis, Grigorios; (2022). Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial. British Journal of Cancer, 127.0(4), 695-703.
• Tsaousis, Georgios N; Papadopoulou, Eirini; Agiannitopoulos, Konstantinos; Pepe, Georgia; Tsoulos, Nikolaos; et al. (2022). Revisiting the implications of positive germline testing results using multi-gene panels in breast cancer patients. Cancer Genomics & Proteomics, 19.0(1), 60-78.
• Gravvanis, Andreas; Venizelos, Vasilis; (2021). Direct-to-Implant, Prepectoral Breast Reconstruction: A Single-Surgeon Experience with 201 Consecutive Patients. Plastic and Reconstructive Surgery, 148.0(1), 142e-143e.
• Agiannitopoulos, Konstantinos; Pepe, Georgia; Papadopoulou, Eirini; Tsaousis, Georgios N; Kampouri, Stavroula; Maravelaki, Sonia; Fassas, Athanassios; Christodoulou, Christos; Iosifidou, Rodoniki; Karageorgopoulou, Sofia; (2021). Clinical utility of functional RNA analysis for the reclassification of splicing gene variants in hereditary cancer. Cancer Genomics & Proteomics, 18.0(3), 285-294.
• Triantafyllia Koletsa, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Manousou, Sofia Chrisafi, Flora Zagouri, et al. (2020). Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density? Cancer Immunology, Immunotherapy, 69(8).
• Tsaousis, G. N., Papadopoulou, E., Apessos, A., Agiannitopoulos, K., Pepe, G., Kampouri, S.,et al. (2019). Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations. BMC cancer, 19(1), 1-19
• Goussia, A., Simou, N., Zagouri, F., Manousou, K., Lazaridis, G., Gogas, H., et al. (2018). Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial. Plos one, 13(7), e0200302.
• Apessos, A., Agiannitopoulos, K., Pepe, G., Tsaousis, G. N., Papadopoulou, E., Metaxa-Mariatou, V.,et al. (2018). Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center. Cancer genetics, 220, 1-12.
• Timotheadou, E., Kalogeras, K. T., Koliou, G. A., Wirtz, R. M., Zagouri, F., Koutras, A., et al. (2017). Evaluation of the prognostic value of RANK, OPG, and RANKL mRNA expression in early breast cancer patients treated with anthracycline-based adjuvant chemotherapy. Translational Oncology, 10(4), 589-598
• Markopoulos, C., Koukouras, D., Venizelos, V., Karyda, I., Xepapadakis, G., Misitzis, J., et al. (2016). Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons. The Breast, 27, 27-34.
• Markopoulos, C., Tzoracoleftherakis, E., Koukouras, D., Venizelos, B., Zobolas, V., Misitzis, et al. (2012). Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial. Journal of Cancer Research and Clinical Oncology, 138, 1569-1577
• Markopoulos, C., Xepapadakis, G., Venizelos, V., Tsiftsoglou, A., Misitzis, J., Panoussis, D., et al. (2012). Clinical experience of using oncotype DX as an additional treatment decision tool in early breast cancer–A retrospective analysis from 5 Greek institutions. European Journal of Surgical Oncology (EJSO), 38(5), 413-419
• Xepapadakis, G., Ntasiou, P., Koronarchis, D., Koufoudakis, D., Panousis, D., Grosomanidis, D., et al. (2010). New views on treatment of aromatase inhibitors induced arthralgia. The Breast, 19(3), 249-250
• Markopoulos, C., Tzoracoleftherakis, E., Polychronis, A., Venizelos, B., Dafni, U., Xepapadakis, G.,et al. (2010). Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast cancer research, 12(2), 1-12.
• Markopoulos, C., Dafni, U., Misitzis, J., Zobolas, V., Tzoracoleftherakis, E., Koukouras, D., et al. (2009). Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy. Breast Cancer Research, 11, 1-9
• Dixon, J. M., Venizelos, B., & Chan, P. (2002). Latissimus dorsi mini-flap: a technique for extending breast conservation. The Breast, 11(1), 58-65
• Byrne, G. J., Ghellal, A., Iddon, J., Blann, A. D., Venizelos, V., Kumar, S., et al. (2000). Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. Journal of the national cancer institute, 92(16), 1329-1336.
• Dixon, J. M., Venizelos, B., & Matheson, L. (1998). Breast lumps in young women. New technique has excellent cosmetic results. BMJ (Clinical research ed.), 317(7152), 209-210.
• Byrne, G. J., Blann, A. D., Venizelos, V., Iddon, J., Howell, A., & Bundred, N. J. (1998). Serum soluble VCAM: a surrogate marker of angiogencsis. Breast Cancer Research and Treatment, 50, 559-559
• Venizelos, B., Chan, P., & Dixon, J. M. (1998). Latissimus dorsi miniflap: a technique for extending breast conservation. Breast Cancer Research And Treatment, 50, 247-247
• Venizelos, B., Ghellal, A., Baird, P., Hoyland, J. A., Kumar, S., Freemont, A. J., & Bundred, N. J. (1997). 0-90. Association of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) with microvessels density in invasive ductal carcinoma of the breast. The Breast, 4(6), 249-250.

Publications in the proceedings of International Congresses (Peer reviewed)

• Venizelos, V., Iosifidou, R., Markopoulos, C., Xepadakis, G., Tsoulos, N., Giannoulakis, S., ... & Stathoulopoulou, M. (2025). Abstract P4-09-29: PR status cannot predict Oncotype DX Recurrence Score®: a study in a Greek cohort of N0M0/ER+/PR-/HER2-breast cancer patients tested with Oncotype DX. Clinical Cancer Research, 31(12_Supplement), P4-09.
• Iosifidou, R., Xepapadakis, G., Venizelos, V., Markopoulos, C., Papazisis, K., Tsoulos, N., ... & Koinis, F. (2025). P050: Genomic risk assessment with Oncotype DX in youngwomen (age≤ 40 years old) with early-stage ER+/HER2-/N0 breast cancer. The Breast, 80.
• Markopoulos, C., Koumarianou, A., Venizelos, V., Iosifidou, R., Papazisis, K., Tsoulos, N., ... & Matheos, D. (2025). P049: The prognostic role of Ki-67 in relation to Oncotype DX Recurrence Score. The Breast, 80.
• Matiatou, M., Stathoulopoulou, M., Trigkas, V., Marousopoulou, E., Karamanis, P., & Venizelos, V. (2024). Sentinel lymph nodes intraoperative frozen section analysis: Is it necessary in all patients?. European Journal of Surgical Oncology, 50.
• Tsoulos, N., Meintani, A., Kapetsis, G., Chatzigiannidou-Florou, C., Tsantikidi, A., Maxouri, S., ... & Nasioulas, G. (2024). Abstract PO5-04-13: Liquid Biopsy Testing in a Greek Cohort of ER-positive, HER2-negative metastatic breast cancer patients. Cancer Research, 84(9_Supplement), PO5-04.
• Matiatou, M; Gravvanis, A; Syrgiannis, K; Balitsaris, E; Karamanis, P; Trigkas, V; Stathoulopoulou, M; Venizelos, V; (2023). Oncoplastic techniques allow extensive breast tissue resections in case of multiple breast lesions: A case report. European Journal of Surgical Oncology, 49.0(2), e90.
• Matiatou, M; Alafaki, M; Syrgiannis, K; Trigkas, V; Vrettou, A; Marousopoulou, E; Vintzileou, I; Stathoulopoulou, M; Venizelos, V; (2023). P067 The effect of COVID-19 pandemic on the use of Vacuum Assisted Breast Biopsy: An opportunity for change in Greece? The Breast, 68.0(nan), S41.
• Syrgiannis, K; Matiatou, M; Varaki, K; Vrettou, A; Trigkas, V; Karamanis, P; Stathoulopoulou, M; Venizelos, V; (2023). P300 Evaluation of preoperative breast MRI findings in breast cancer patients. The Breast, 68.0(nan), S135.
• Ziogas, D; Agiannitopoulos, K; Pepe, G; Potska, K; Tsaousis, G; Apostolopoulou, D; Tsoulos, N; Venizelos, V; Markopoulos, C; Iosifidou, R;(2022). 1709P Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes. Annals of Oncology, 33.0(nan), S1321.
• Zagouri, Flora; Koliou, Georgia-Angeliki; Dimitrakopoulos, Foteinos; Papadimitriou, Christos; Binas, Ioannis; Koutras, Angelos; Papakostas, Pavlos; Markopoulos, Christos; Venizelos, Vasileios; Xepapadakis, Grigorios; (2022). Abstract P1-12-01: Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: Final long-term results of the hellenic cooperative oncology group phase III HE10/05 trial. Cancer Research, 82.0(4_Supplement), P1-12-01-P1-12-01.
• Tsoulos, Nikolaos; Agiannitopoulos, Konstantinos; Pepe, Georgia; Papadopoulou, Eirini; Tsaousis, Georgios N; Apostolopoulou, Despina; Meintani, Angeliki; Venizelos, Vassileios; Markopoulos, Christos; Iosifidou, Rodoniki; (2022). Abstract P2-09-10: Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing. Cancer Research, 82.0(4_Supplement), P2-09-10-P2-09-10.
• Agiannitopoulos, K; Pepe, G; Papadopoulou, E; Tsaousis, G; Kampouri, S; Maravelaki, S; Fassas, A; Christodoulou, C; Iosifidou, R; Karageorgopoulou, S; (2020). Splicing variants in hereditary cancer genes: clinical utility of functional RNA analysis. European Journal of Human Genetics, 28.0(SUPPL 1), 538-539
• Tsaousis, GN; Tsoulos, N; Papadopoulou, E; Agiannitopoulos, K; Pepe, G; Diamantopoulos, N; Floros, TI; Iosifidou, R; Markopoulos, C; Papazisis, K; (2019). Multigene panel testing results for hereditary breast cancer in 1325 individuals: Implications for gene selection and considerations for guidelines. Annals of Oncology, 30.0(nan), v36
• Tsoulos, N; Tsaousis, GN; Papadopoulou, E; Agiannitopoulos, K; Pepe, G; Kambouri, S; Apessos, A; Diamantopoulos, N; Floros, T; Iosifidou, R; (2019). Abstract P4-03-07: Analysis of hereditary cancer syndromes by using a panel of genes: Novel and multiple pathogenic mutations. Cancer Research, 79.0(4_Supplement), P4-03-07-P4-03-07
• Antonopoulos, D., Stathoulopoulou, M., Trigas, V., Karamanis, P., Syrgiannis, K., Zachari, E., et al. (2018). Immediate reconstruction following mastectomy (one stage) using implant and a titanium-coated polypropylene mesh (TiLOOP bra). European Journal of Cancer, 92, S81-S82.
• Antonopoulos, D., Syrgiannis, K., Zachari, E., Stathoulopoulou, M., Karamanis, P., Trigas, V., et al. (2018). Share Wave Elastography as a method of assessing the response to neoadjuvant chemotherapy treatment for women with breast malignancy. European Journal of Cancer, 92, S81
• Stathoulopoulou, M; Iliopoulos, E; Karamanis, P; Marousopoulou, E; Venizelos, V; (2016). Patients' satisfaction following oncoplastic surgical procedures for breast cancer. European Journal of Cancer, 57.0(nan), S80-S80
• Sthathoulopoulou, M; Iliopoulos, E; Sirgiannis, K; Lazarou, S; Venizelos, V; (2016). Preoperative assessment of axillary lympnodes in clinically negative patients with breast cancer. European Journal of Cancer, 57.0(nan), S80-S81
• Kotoula, V; Fountzilas, E; Chatzopoulos, K; Alexopoulou, Z; Timotheadou, E; Xanthakis, I; Gogas, H; Skondra, M; Christodoulou, C; Papadopoulou, K; (2016). Abstract P2-07-02: Tumor infiltrating lymphocytes density and coding mutations effects on the outcome of operable triple negative breast cancer patients. Cancer Research, 76.0(4_Supplement), P2-07-02-P2-07-02
• V Kotoula, E Fountzilas, K Chatzopoulos, Z Alexopoulou, E Timotheadou, et al. (2016). Abstract P2-07-02: Tumor infiltrating lymphocytes density and coding mutations effects on the outcome of operable triple negative breast cancer patients. Cancer Res, 76 (4_Supplement): P2-07-02
• Fountzilas, George; Dimopoulos, Meletios A; Kouvatseas, George; Timotheadou, Eleni; Pentheroudakis, et al. (2015). Effect of mutant TP53 genotypes on the outcome of breast cancer (BC) patients in different clinical tumor subtypes. Journal of Clinical Oncology 33, no. 15-suppl, 11041-11041
• Apessos, A., Papadopoulou, E., Metaxa-Mariatou, V., Agiannitopoulos, K., Markopoulos, C., Venizelos, V., et al. (2015). Different genomic rearrangements account for 17% of BRCA1/2 mutations in Greece. Cancer Res, 75(9 Suppl), P1-03
• Markopoulos, C., Koukouras, D., Xepapadakis, G., Venizelos, V., Tzoracoleftherakis, E., Misitzis, J., et al. (2014, March). Age effect on treatment decision for adjuvant chemotherapy in women with ER-positive early breast cancer: analysis of the basic data of the POCHARBI trial, an observational study conducted by the Hellenic Society of Breast Surgeons. In European Journal of Cancer (Vol. 50, pp. S82-S82)
• Venizelos, V., Stathoulopoulou, M., Gremoutis, G., & Kretsis, V. (2014, March). Oncoplastic techniques applied in patients with operable breast cancer. In European Journal of Cancer (Vol. 50, pp. S156-S156)
• Venizelos, V., Gremoutis, G., Stathoulopoulou, M., & Kretsis, V. (2014, March). Delayed-immediate breast reconstruction after radiotherapy. In European Journal of Cancer (Vol. 50, pp. S155-S155)
• Markopoulos, C., Koukouras, D., Xepapadakis, G., Venizelos, B., Tzoracoleftherakis, E., Zobolas, V., et al. (2014, March). Impact of chemotherapy followed by aromatase inhibitors on bone health in women with ER-positive early breast cancer: Preliminary results of the POCHARBI trial, an observational study conducted by the Hellenic Society of Breast Surgeons. In European Journal of Cancer (Vol. 50, pp. S52-S52)
• Markopoulos, C., Xepapadakis, G., Venizelos, V., Tsiftsoglou, A., Misitzis, J., Panoussis, D., Antonopoulou, Z., Stathoulopoulou, M., Zobolas, V., & Gogas, H. (2012). Clinical experience of using oncotype DX as an additional treatment decision tool in early breast cancer – A retrospective analysis from 5 Greek institutions. European Journal of Surgical Oncology (EJSO), 38(5), 413–419. https://doi.org/10.1016/J.EJSO.2012.02.183
• Markopoulos, C., Xepapadakis, G., Venizelos, V., Tsiftsoglou, A., Misitzis, J., Panoussis, D., et al (2011). Clinical Use of OncotypeDX Recurrence Score as an Adjuvant-Treatment Decision Tool in Early Breast Cancer Patients. European Journal of Cancer, (47), S379
• Xepapadakis, G., Ntasiou, P., Koronarchis, D., Koufoudakis, D., Panousis, D., Gosomanidis, D., et al. (2010). 367 New views on treatment of aromatase inhibitors induced arthralgia. European Journal of Cancer Supplements, 8(3), 164-165
• Markopoulos, C; Tzorakoleftherakis, E; Polychronis, A; Venizelos, V; Xepapadakis, G; Kalogerakos, K; Papadiamantis, J; Zobolas, V; Janinis, J; Dafni, U; (2009). Management of bone loss in breast cancer patients: 24-month results from the ARBI trial of anastrozole with risedronate. Journal of Clinical Oncology, 27.0(15_suppl), 552-552
• Venizelos V., Chan P., Dixon M. (1999). Latissimus Dorsi miniflap: a technique for extending breast conservation. The Breast; Vol 8; Number 4; page231
• Venizelos, B., Chan, P., & Dixon, J. M. (1998). Latissimus dorsi miniflap: a technique for extending breast conservation. Breast Cancer Research and Treatment, 50, 247-247
• Venizelos B., Walsh J., Dixon J.M. (1999). Life span of silicone implants and identification of rupture using a combination of ultrasonography (US) and breast magnetic resonance imaging (MRI). The Breast; Vol 8; Number 4; page231
• Byrne, G. J., Blann, A. D., Venizelos, V., Howell, N. J., & Bundred, A. (1998). Serum soluble VCAM: A surrogate marker of angiogenesis. European Journal of Cancer, 34(1005), S117-S117
• Venizelos B., Lambah A, Chiarello M.M., Chetty U; Dixon J.M. (1998). The use of second-generation silicone gel filled implants in immediate breast reconstruction following mastectomy for breast cancer. The Breast Journal, Vol 4; Suppl1
• Venizelos, B., Blair, P., Holland, J., Freemont, A. F., & Bundred, N. J. (1998). Expression of hepatocyte growth factor/scatter factor in primary breast cancer. European Journal of Cancer, 34(1001), S22-S22
• Venizelos, B., Chan, P., Greenwood, S., Dillon, P., & Dixon, J. M. (1998). Preoperative factors influencing complete excision of palpable breast cancer in breast conserving therapy. European Journal of Cancer, 34(1005), S50-S50
• Venizelos, B., Chan, P., Lambah, A., Chiarello, M. M., Chetty, U., & Dixon, J. M. (1998). Morbidity following immediate breast reconstruction (IBR) after mastectomy. European Journal of Cancer, 34(1005), S27-S27
• Venizelos B., Hoyland J..A, Baird P.A., Knox W.F., Bundred N.J. (1997). Use of IN SITU hybridization to study the expression of Vascular Endothelial Growth factor (VEGF) and one of its receptors (FLT-1) in breast cancer and bone metastases. The Bone, Vol 20; Num 4 (Supplement)
• Venizelos B., Hoyland J.A., Baird P., Freemont J., Bundred N.J. (1997). Bone metastases in breast cancer and association with vascular endothelial growth factor and its receptors. European Journal of Surgical Oncology; Vol 23; Num 4
• Byrne, G. J., Blann, A. D., Venizelos, V., Iddon, J., Howell, A., & Bundred, N. J. (1997). 0-91. Serum vascular endothelial cell marker (VCAM) and e-selectin (Esel) are endothelial markers for angiogenesis in early and advanced breast cancer. The Breast, 4(6), 250

Including but not limited to round table discussions, symposium presentations, conference chair, keynote speaker, session chair, paper discussant and conference organizing:

• President of Organizing Committee and Moderator (President of HBSS). 11^th Panhellenic Congress of Hellenic Breast Surgical Society, 2025
• President of Organizing Committee and Moderator (President of HBSS). 10^th Panhellenic Congress of Hellenic Breast Surgical Society, 2024
• President of Organizing Committee and Moderator (President of HBSS). 9^th Panhellenic Congress of Hellenic Breast Surgical Society, 2023
• President of Organizing Committee. Hellenic Breast Surgical Society (HBSS) meets breastics24h: International virtual MDT with live voting; critical decisions in borderline cases. Webinar, 2023
• Chairman of round table. Radiotherapy in breast cancer. special topics for the breast surgeon, Hellenic Interdisciplinary Breast Cancer Society (EDEKMA), 2023
• Chairman. Radiotherapy and Breast Cancer. Special topics for the Breast Surgeon, One day meeting, 2023;
• Chairman. Breast cancer today: dilemmas and therapeutic perspectives – Webinar, 2023
• Commentator: Breast radiology innovation course (B.R.I.C. 2022), 2022
• President of Organizing Committee. Breast cancer from start to finish. early diagnosis to comprehensive treatment (Hellenic interdisciplinary breast cancer society - EDEKMA), 2022
• Member of Scientific Committee. 4rth Hands-on seminar on breast and oncoplastic surgery, 2022
• President of Organizing Committee. 8th Panhellenic congress of Hellenic Society of Breast Surgeons, 2022
• President of Scientific Committee: MDT with live voting – Webinar, 2022
• Member of Scientific Committee and Coordinator. Precision medicine in breast cancer and special topics, 2021
• Coordinator. Multidisciplinary meeting and cases discussion – Webinar, 2021
• Coordinator. Breast radiology innovation course (b.r.i.c. 2021) -Webinar, 2021
• Member of Scientific Committee and Coordinator. Oncoplastic and reconstructive breast surgery controversies and new directions – Webinar, 2021
• Member of Scientific Committee and Coordinator. Pre-surgical diagnosis and minimum invasive techniques in breast lesions, 2021
• Member of Scientific Committee and hands on Instructor. 3rd Hands-on seminar on breast and oncoplastic surgery, 2021
• Member of Scientific Committee and Coordinator. Precision medicine in breast cancer and special topics, 2021
• President of Organizing Committee (President HBSS). Hellenic guidelines for the preoperative management of breast cancer patients, 2020
• Coordinator and member of Scientific Committee. New data in the treatment of breast cancer - Webinar, 2020
• Coordinator and member of Scientific Committee. Prepectoral implant reconstruction following mastectomy - Webinar, 2020
• Coordinator and member of Scientific Committee. Pre-surgical diagnosis and minimum invasive techniques in breast lesions – Webinar, 2020
• Member of Scientific Committee and speaker. Breast cancer in clinical management and contemporary challenges – Webinar, 2020
• Member of Scientific Committee and Coordinator. Planning and surgical strategy after preoperative chemotherapy – Webinar, 2020
• Coordinator and member of scientific committee. Immediate Breast Reconstruction with Implants – Webinar, 2020
• President of Organizing Committee (President of HBSS). 7th Panhellenic Congress of Hellenic Breast Surgical Society, 2019
• Member of Scientific Committee and hands-on Instructor. 2^nd Hands on Seminar on Breast and Oncoplastic Surgery, 2019
• Member of Scientific Committee and hands on-Instructor. Day of Digital Tomosynthesis of Masterfully Guided Biopsies, 2019
• President of Organizing Committee (President of HBSS). 6th Panhellenic Congress of Hellenic Breast Surgical Society, 2018
• Member of Scientific Committee and hands on Instructor. 1st Hands on Seminar on Breast and Oncoplastic Surgery, 2018
• Member of Scientific Committee and hands-on Instructor. Ultrasound Seminar- Breast Elastography Workshop Hands-on, 2018
• Member of Scientific Committee and hands-on Instructor. Tomosynthesis Digital Mammography Conference CESM, 2018

President of the Hellenic Breast Surgical Society (HBSS)

President of the Hellenic Interdisciplinary Breast Cancer Society (EDEKMA)
Member of the American Society of Breast Surgeons
Honorary Fellow of European Board of Surgery (F.E.B.S.), Breast Surgery
Member of the Medical Association of Athens
Member of the Medical Association of Piraeus
Member of the Medical Association of Patras
Other:

Member of the working group of Central Board of Health (KESY – advisory body related to the structure and operation of Greek National Health System) for the determination of the requirements of medical sup-specialty in Breast Surgery (July 2023-now

Research:

3^rd Best Oral Presentation Award for “The use of polyurethane implants in direct to implant (D.T.I.) breast reconstruction: 6 years’ experience”. Antonopoulos D, Antonopoulos M, Matiatou M, Trigkas V, Marousopoulou E, Karamanis P, Stathoulopoulou m, Venizelos V. Presented at the 9^thPanhellenic Congress of Hellenic Breast Surgical Society, 2023

2^nd Best Poster Presentation Award for “Selective denervation of pectoralis major during sub-pectoral implant breast reconstruction to eliminate animation deformity”. Antonopoulos M, Antonopoulos D, Stathoulopoulou M, Karamanis P, Venizelos V. Presented at the 9^thPanhellenic Congress of Hellenic Breast Surgical Society, 2023

1st Best Oral Presentation Award for “Mastectomy and Immediate Breast Reconstruction with the S.I.M.P.L.E.® Breast Reconstruction technique” Antonopoulos D, Stathoulopoulou M, Matiatou M, Trigkas V, Antonopoulos M, Venizelos V. Presented at the 8^th Panhellenic Congress of Hellenic Breast Surgical Society, 2022

2nd Best Oral Presentation Award for “The use of stereotactic breast biopsy durind the COVID-19 pandemic” Matiatou M, Alafaki M, Syrgiannis K, Vrettou A, Trigkas V, Marousopoulou E, Vintzileou I, Polonyfi E, Stathoulopoulou M, Venizelos V. Presented at the 8^th Panhellenic Congress of the Hellenic Breast Surgical Society, 2022

Accolade for the Oral Presentation “Evaluation of preoperative Breast MRI findings in patients with a known breast cancerous lesion” Syrgiannis K, Varagki K, Stathoulopoulou M, Vretou A, Trigkas V, Matiatou M, Venizelos V. Presented at the 8^th Panhellenic Congress of the Hellenic Breast Surgical Society, 2022

3^rd Best Oral Presentation Award for “Biopsy and localization under MRI guidance of breast lesions seen only on breast MRI” Varagki K, Samiotis K, Stathoulopoulou M, Venizelos V. Presented at the 6^th Panhellenic Congress of the Hellenic Breast Surgical Society, 2018

2^nd Best Oral Presentation Award for “Mastectomy and Immediate Breast Reconstruction with the use of implant and TiLOOP- BRA mesh (One stage technique)-Our 3 years’ experience Antonopoulos D, Stathoulopoulou M, Trigkas V, Karamanis P, Syrgiannis K, Marousopoulou E, Antonopoulos M, Venizelos V Presented at the 6^th Panhellenic Congress of the Hellenic Breast Surgical Society, 2018

3^rd Best Oral Presentation Award for “Percutaneous Breast Biopsy: A precise method to decide neoadjuvant therapy upon immunohistochemistry of the tumor”. Presented at the 6^th Panhellenic Congress of the Hellenic Breast Surgical Society, 2018

1^st Breast Poster Presentation for “Protocol for quantitative measurements of breast lesions’ shear wave elastography” Lazarou S, Loypas A, Michalopoulos A, Syrgiannis K, Stathoulopoulou M, Venizelos Presented at the 3^st Panhellenic Congress of the Hellenic Breast Surgical Society, 2015

Accolade for the Oral Presentation “Skin sparing mastectomy and breast reconstruction with free abdominal flaps” Kretsis V, Gremoutis G, Stathoulopoulou M, Venizelos V Presented at 10^ο Συνέδριο Πλαστικής και Επανορθωτικής Χειρουργικής, 2013

1^st Best Oral Presentation Award for “Reliability of frozen section using immunohistochemistry to identify metastasis and isolated tumor cells in sentinel lymph node of early breast cancer patients” Nika E, Petraki K, Stathoulopoulou M, venizelos V Presented at the 1^st Panhellenic Congress of the Hellenic Breast Surgical Society, 2010

Business Awards:

2024, Silver Award, Healthcare Business Awards for “Multidisciplinary Breast Center: An integrated unit for the prevention, diagnosis, and treatment of breast diseases has been certified by European Society of Breast Cancer Specialists”

2021, Bronze Award, Healthcare Business Awards for “Advanced medical care services for breast cancer patients during covid-19 pandemic period”

2020, Bronze Award, Healthcare Business Awards for “Innovative Breast Unit of a Private Hospital”

2020, Silver Award, Healthcare Business Awards for Vacuum assisted biopsy under local anesthesia for histological diagnosis of suspicious B4 microcalcifications

2019, Bronze Award, Healthcare Business Awards for “Pioneering Therapeutic Approach to rehabilitation after mastectomy and reconstruction”

Other:

Honored by the Panhellenic Association of Women with Breast Cancer- ALMA ZOIS

E-mail: basilvenizelos@gmail.com

Telephone: +302104809925